Literature DB >> 26475403

Using ethyl glucuronide in urine to detect light and heavy drinking in alcohol dependent outpatients.

Michael G McDonell1, Jordan Skalisky2, Emily Leickly3, Sterling McPherson4, Samuel Battalio3, Jenny R Nepom2, Debra Srebnik3, John Roll4, Richard K Ries3.   

Abstract

AIMS: This study investigated which ethyl glucuronide immunoassay (EtG-I) cutoff best detects heavy versus light drinking over five days in alcohol dependent outpatients.
METHODS: A total of 121 adults with alcohol use disorders and co-occurring psychiatric disorders took part in an alcohol treatment study. Participants provided self-reported drinking data and urine samples three times per week for 16-weeks (total samples=2761). Agreement between low (100 ng/mL, 200 ng/mL), and moderate (500 ng/mL) EtG-I cutoffs and light (women ≤3 standard drinks, men ≤4 standard drinks) and heavy drinking (women >3, men >4 standard drinks) were calculated over one to five days.
RESULTS: The 100 ng/mL cutoff detected >76% of light drinking for two days, and 66% at five days. The 100 ng/mL cutoff detected 84% (1 day) to 79% (5 days) of heavy drinking. The 200 ng/mL cutoff detected >55% of light drinking across five days and >66% of heavy drinking across five days. A 500 ng/mL cutoff identified 68% of light drinking and 78% of heavy drinking for one day, with detection of light (2-5 days <58%) and heavy drinking (2-5 days <71%) decreasing thereafter. Relative to 100 ng/mL, the 200 ng/mL and 500 ng/mL cutoffs were less likely to result in false positives.
CONCLUSIONS: An EtG-I cutoff of 100 ng/mL is most likely to detect heavy drinking for up to five days and any drinking during the previous two days. Cutoffs of ≥500 ng/mL are likely to only detect heavy drinking during the previous day.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Alcohol biomarkers; Assessment of cut-off; Ethyl glucuronide in urine; Heavy drinking

Mesh:

Substances:

Year:  2015        PMID: 26475403      PMCID: PMC4663163          DOI: 10.1016/j.drugalcdep.2015.10.004

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  13 in total

Review 1.  Truth or consequences: the validity of self-report data in health services research on addictions.

Authors:  F K Del Boca; J A Noll
Journal:  Addiction       Date:  2000-11       Impact factor: 6.526

Review 2.  The validity of self-reported cost events by substance abusers. Limits, liabilities, and future directions.

Authors:  J Langenbucher; J Merrill
Journal:  Eval Rev       Date:  2001-04

3.  Clinical (nonforensic) application of ethyl glucuronide measurement: are we ready?

Authors:  Peter Jatlow; Stephanie S O'Malley
Journal:  Alcohol Clin Exp Res       Date:  2010-04-05       Impact factor: 3.455

4.  Sensitivity and specificity of urinary ethyl glucuronide and ethyl sulfate in liver disease patients.

Authors:  Scott H Stewart; David G Koch; Douglas M Burgess; Ira R Willner; Adrian Reuben
Journal:  Alcohol Clin Exp Res       Date:  2012-06-22       Impact factor: 3.455

5.  Talk is cheap: measuring drinking outcomes in clinical trials.

Authors:  T F Babor; K Steinberg; R Anton; F Del Boca
Journal:  J Stud Alcohol       Date:  2000-01

6.  Alcohol biomarkers in applied settings: recent advances and future research opportunities.

Authors:  Raye Z Litten; Ann M Bradley; Howard B Moss
Journal:  Alcohol Clin Exp Res       Date:  2010-04-05       Impact factor: 3.455

7.  Ethyl glucuronide: a marker of recent alcohol consumption with clinical and forensic implications.

Authors:  F M Wurst; C Kempter; J Metzger; S Seidl; A Alt
Journal:  Alcohol       Date:  2000-02       Impact factor: 2.405

8.  Urinary ethyl glucuronide and ethyl sulfate testing for detection of recent drinking in an outpatient treatment program for alcohol and drug dependence.

Authors:  Helen Dahl; Annette Voltaire Carlsson; Kristina Hillgren; Anders Helander
Journal:  Alcohol Alcohol       Date:  2011-02-20       Impact factor: 2.826

9.  Primary outcome indices in illicit drug dependence treatment research: systematic approach to selection and measurement of drug use end-points in clinical trials.

Authors:  Dennis M Donovan; George E Bigelow; Gregory S Brigham; Kathleen M Carroll; Allan J Cohen; John G Gardin; John A Hamilton; Marilyn A Huestis; John R Hughes; Robert Lindblad; G Alan Marlatt; Kenzie L Preston; Jeffrey A Selzer; Eugene C Somoza; Paul G Wakim; Elizabeth A Wells
Journal:  Addiction       Date:  2011-07-22       Impact factor: 6.526

10.  EtG/EtS in Urine from sexual assault victims determined by UPLC-MS-MS.

Authors:  Solfrid Hegstad; Arne Helland; Cecilie Hagemann; Lisbeth Michelsen; Olav Spigset
Journal:  J Anal Toxicol       Date:  2013-03-06       Impact factor: 3.367

View more
  23 in total

1.  Pilot investigation of a phosphatidylethanol-based contingency management intervention targeting alcohol use.

Authors:  Michael G McDonell; Jordan Skalisky; Emily Leickly; Michael F Orr; Sterling McPherson; John Roll; Nathalie Hill-Kapturczak; Martin Javors
Journal:  Psychol Addict Behav       Date:  2017-07-17

2.  Concordance of Self- and Partner-Reported Alcohol Consumption Among Couples Experiencing Intimate Partner Violence in Zambia.

Authors:  Jeremy C Kane; Sarah M Murray; Michael J Vinikoor; M Claire Greene; Shoshanna L Fine; Ravi Paul; Laura K Murray
Journal:  Alcohol Clin Exp Res       Date:  2019-10-20       Impact factor: 3.455

3.  Randomized controlled trial of harm reduction treatment for alcohol (HaRT-A) for people experiencing homelessness and alcohol use disorder.

Authors:  Susan E Collins; Seema L Clifasefi; Lonnie A Nelson; Joey Stanton; Silvi C Goldstein; Emily M Taylor; Gail Hoffmann; Victor L King; Alyssa S Hatsukami; Zohar Lev Cunningham; Ellie Taylor; Nigel Mayberry; Daniel K Malone; T Ron Jackson
Journal:  Int J Drug Policy       Date:  2019-03-06

4.  Pretreatment ethyl glucuronide levels predict response to a contingency management intervention for alcohol use disorders among adults with serious mental illness.

Authors:  Michael Gerard McDonell; Emily Leickly; Sterling McPherson; Jordan Skalisky; Katherine Hirchak; Oladunni Oluwoye; Debra Srebnik; John Michael Roll; Richard Kirkland Ries
Journal:  Am J Addict       Date:  2017-08-18

5.  High Agreement Between Benchtop and Point-of-Care Dipcard Tests for Ethyl Glucuronide.

Authors:  Emily Leickly; Jordan Skalisky; Sterling McPherson; Michael F Orr; Michael G McDonell
Journal:  Ther Drug Monit       Date:  2017-08       Impact factor: 3.681

6.  Using a randomized controlled trial to test whether modifications to contingency management improve outcomes for heavy drinkers with serious mental illness.

Authors:  Oladunni Oluwoye; Jordan Skalisky; Ekaterina Burduli; Naomi S Chaytor; Sterling McPherson; Sean M Murphy; Jalene Herron; Katherine Hirchak; Mason Burley; Richard K Ries; John M Roll; Michael G McDonell
Journal:  Contemp Clin Trials       Date:  2018-04-20       Impact factor: 2.226

7.  Contingency management intervention targeting co-addiction of alcohol and drugs among American Indian adults: Design, methodology, and baseline data.

Authors:  Ekaterina Burduli; Jordan Skalisky; Katherine Hirchak; Michael F Orr; Albert Foote; Alexandria Granbois; Richard Ries; John M Roll; Dedra Buchwald; Michael G McDonell; Sterling M McPherson
Journal:  Clin Trials       Date:  2018-08-29       Impact factor: 2.486

8.  Serious Mental Illness in Heavy Drinkers Is Associated with Poor Treatment Outcomes in Outpatients with Co-occurring Disorders.

Authors:  Oladunni Oluwoye; Emily Leickly; Jordan Skalisky; Sterling McPherson; Katherine Hirchak; Debra Srebnik; John M Roll; Richard K Ries; Michael G McDonell
Journal:  Int J Ment Health Addict       Date:  2017-10-31       Impact factor: 3.836

9.  Pilot investigation: randomized-controlled analog trial for alcohol and tobacco smoking co-addiction using contingency management.

Authors:  Michael F Orr; Crystal Lederhos Smith; Myles Finlay; Samantha C Martin; Olivia Brooks; Oladunni A Oluwoye; Emily Leickly; Michael McDonell; Ekaterina Burduli; Celestina Barbosa-Leiker; Matt Layton; John M Roll; Sterling M McPherson
Journal:  Behav Pharmacol       Date:  2018-08       Impact factor: 2.293

10.  Homelessness predicts attrition but not alcohol abstinence in outpatients experiencing co-occurring alcohol dependence and serious mental illness.

Authors:  Emily Leickly; Jordan Skalisky; Oladunni Oluwoye; Sterling M McPherson; Debra Srebnik; John M Roll; Richard K Ries; Michael G McDonell
Journal:  Subst Abus       Date:  2017-12-08       Impact factor: 3.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.